Navigation Links
Nuvo announces first quarter 2008 financial results
Date:5/1/2008

There are more than 21 million Americans suffering from osteoarthritis, a very painful and debilitating condition, and the United States market for this condition is estimated at US$4 billion annually In December 2006, the U.S. Food and Drug Administration issued an approvable letter that indicated Pennsaid(R) is approvable subject to Nuvo satisfying certain conditions.

About Nuvo Research Inc.

Nuvo is a Canadian drug development company primarily focused on the research and development of drug products that are delivered to and through the skin. Nuvo is also involved in research and development activities involving WF10, a chlorite-based, immunomodulating drug through its 60% interest in Dimethaid AG.

Nuvo believes it is uniquely positioned to research and develop new drug product candidates for delivery to and through the skin using its multiplexed molecular penetration enhancers ("MMPE(TM)"s), that interact with the skin and enhance its permeability thereby allowing certain drug molecules to pass into and through the skin to proximate tissues and its high throughput experimentation systems that allow its scientists to rapidly screen combinations of existing molecular penetration enhancers ("MPE(TM)s") with large numbers of potential drug formulations to measure their ability to permeabilize and permeate the skin. Nuvo's lead product Pennsaid(R), a topical non-steroidal anti-inflammatory drug (NSAID) utilizes the Company's technology to treat the symptoms of osteoarthritis of the knee locally. Nuvo intends to leverage its technologies to create a portfolio of topical and transdermal products targeting a variety of indications. Nuvo Research Inc. is a publicly traded company headquartered in Mississauga, Ontario, with manufacturing facilities in Varennes, Quebec and Wanzleben, Germany and a research and development facility in San Diego, California. For more information, please visit http://w
'/>"/>

SOURCE Nuvo Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Brookdale Announces First Quarter 2008 Release and Earnings Call
2. Brown & Toland Announces 2007 Financial Results
3. NightHawk Radiology Holdings, Inc. Announces Appointment of David Engert to the Board of Directors
4. NUCRYST Announces Management Realignment and R&D Portfolio Change
5. West Pharmaceutical Services, Inc. Announces Annual Meeting Webcast
6. Renowned ENT Specialist, Dr. Murray Grossan, Announces Medical Breakthrough on Snoring at PRI-MED Convention in Anaheim on May 15-17
7. GSK Announces Changes to Corporate Executive Team
8. Summit VetPharm Announces New Distributor Partnership with Webster Veterinary
9. Psychemedics Corporation Announces First Quarter Results
10. InfoLogix Announces First Quarter 2008 Financial Results
11. Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Petersburg, FL (PRWEB) November 22, 2014 ... Kitchen Innovations are pleased to announce that Ashley ... the Thanksgiving #PayItForward contest. , Ms. Lombardo entered ... from Kitchen Innovations. She wrote of how her friend ... young daughters as a single mom. Despite medical bills ...
(Date:11/22/2014)... November 22, 2014 Sandbridge Capital, ... investments in the consumer brand sector, acquired a ... will be used to help fund BackJoy’s global ... rollout, particularly its proprietary apparel and footwear lines. ... BackJoy’s Board of Directors. , BackJoy is a ...
(Date:11/22/2014)... 22, 2014 Developers and plugin specialist of ... entitled FCPX 3D Model bringing the impossible to FCPX ... users to add obj files to FCPX enabling 3d Model ... the line between professional and armature, FCPX 3D Model is ... Studios allows Final Cut Pro X users to upload and ...
(Date:11/22/2014)... 22, 2014 Wright & Schulte LLC ... lawsuits have been scheduled between October 2016 and ... of Illinois. U.S. District Judge Matthew F. Kennelly, who ... Management Order (CMO) on November 6, 2014 that outlined ... to submit documents and other activities in preparation for ...
(Date:11/22/2014)... FRIDAY, Nov. 21, 2014 (HealthDay News) -- A clinical ... anemia has been halted a year early because the ... to manage the disease and reduce the risk of ... conducted at 25 medical centers in the United States ... National Heart, Lung, and Blood Institute (NHLBI). Researchers ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2
... planning association all worked up. With the fertility rate ... demographers are pressing the need of 2.1 children per ... ,A survey conducted by the Family Planning Association revealed ... indulge in sex for over a month. There was ...
... must before marriage, say an overwhelming 91 percent in an ... cases.// ,The survey, conducted by manoramaonline/yuva, saw 22,578 ... certificate was a must before marriage. Just 2,032 said that ... have just been published. ,According to the Kerala ...
... is only for the white collar tech-savvy urbanites, think again. ... acquired smart// cards to avail themselves of discounts on daily ... 500 disorganised sex workers in Mysore and Mandya districts of ... prompt them to get regular health check ups to keep ...
... and less inclined to follow a career in general practice, ... of Australia.// ,Dr Catherine Joyce, Senior Lecturer in ... and co-author of the study, says places in the general ... of the past six years. ,The study compared ...
... the growing problem of obesity in Australians by looking at ... in the latest edition of The Medical Journal of Australia, ... (GP) about weight management. ,Levels of overweight and ... past two decades. ,Dr Daisy Tan, Advanced ...
... "Lets Stop Aids Org" is currently touring South Africa to ... living with HIV/Aids.// ,Betty Chiu, a member of ... week. She is encouraging other youngsters to follow her example ... 'Lets Stop Aids Org' was established three years ago at ...
Cached Medicine News:Health News:Majority of Keralites Vote in Favor of HIV Certificate Before Marriage 2Health News:Sex Workers Adopt IT Solutions to Fight AIDS 2
(Date:11/21/2014)... 2014  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... Award for Vision, Innovation, and Leadership has been awarded to ... award recognizes an individual who has had a significant impact ... for several decades. "I am honored to ... Peltz , Ph.D., CEO of PTC Therapeutics, Inc. "When I ...
(Date:11/21/2014)... NEW YORK , Nov. 20, 2014  Market research ... as the "Year of The Buy, in the medical ... market for medical devices will produce just 3% growth ... competitive actions, including acquisitions of product lines and entrance ... an annual survey of medical devices, The Global ...
(Date:11/21/2014)... Michael DeMarco (42) erinnert sich ... Februar 2014 zugetragen hat. Seine Tochter Aly Demarco (13) ... Video - http://youtu.be/5cVoMCe0uiE „Man ... Training zu machen", erzählt Michael DeMarco . „Meine ... begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war auf dem Fahrrad, ...
Breaking Medicine Technology:PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
... the Barbara,Ann Karmanos Cancer Institute and Wayne State ... vaccine that has shown to be effective on ... in the September 15 issue,of Cancer Research, a ... ( http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSCANCERINSTITUTELO ,GO), Wei-Zen Wei, Ph.D., professor ...
... Screening May Not Be Necessary For Diabetic Patients, ... Type 2 diabetes in the United States alone. Coronary ... patients with diabetes.,Silent myocardial ischemia is common, and cardiac ... CAD., Data from the Detection of Ischemia in ...
Cached Medicine Technology:DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers 2Screening for Ischemia in Asymptomatic Patients With Type 2 Diabetes: Five- Year Outcomes in the DIAD Study 2
Nursing2006 Drug Handbook Entries include Alerts, dosage adjustments for specific populations, I.V. administration, off-label indications, adverse reactions, and more....
... Guide 2005 includes over 1,000 commonly used ... their selection and administration. Organized alphabetically by ... key data featuring common uses and side ... patient education information. A list of the ...
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy....
Ident-A-Drug gives you quick accurate identification of oral tablets and capsules used in North America....
Medicine Products: